According to the latest report published by Variant Market Research, the global depression drugs market is estimated to reach $18 billion by 2024, from $15 billion in 2016; at a CAGR of 2.6% from 2016 to 2024.
Download Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/sample-request
Rising efficacy and declining side effects of drugsto drive the global depression drugs market
The global depression drugs market is driven by factors such as growth in geriatric population, rising efficacy and declining side effects of drugs, and support from government organizations. Lack of awareness among individuals regarding depression may hamper the market growth. Furthermore, augmenting prevalence of fretfulness & many other depression disorders would provide an opportunity for market players of depression drugs market.
Market Segmentations
The global depression drugs market is classified into product type, application, and geography. Product type segment includes tricyclice antidepressants, serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical antipsychotics, selective serotonin reuptake inhibitors, benzodiazepines, tetracyclic antidepressants, monoamine oxidase inhibitors and other product types. Clinics and hospitals and research centers are covered under the application sub segment. North America (U.S., Mexico, and Canada), Europe (France, Germany, UK, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific) and RoW (Middle East, South America, and Africa) are the key geographical regions included in the global depression drugs market.
Depression Drugs Market Get Table of Content (TOC) @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/toc
Serotonin-norepinephrine reuptake inhibitors (SNRIs), by product type, is estimated to dominated the global market in 2016
Serotonin-norepinephrine reuptake inhibitors (SNRIs)held for the highest market share in 2016, and expected to continue its dominance over the forecast period, 2016 – 2024, due to
Asia-Pacific is estimated to witness fastest CAGR from 2016 to 2024
Asia-Pacific is predicted to grow at a fastest CAGR over the forecast period 2016 to 2024. The growth is attributed to increased demand from emerging countries such as China, Japan, and Australia. Rising awareness among consumers regarding benefits of depression drug is also expected to propel the growth of depression drugs market in the region.
Ask for Customization (Depression Drugs Market) @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/ask-for-customization
Competitive Landscape
The key market players of the market are H. Lundbeck, Merck & Co., SK Biopharmaceuticals, Novartis, AstraZeneca, Forest Laboratories, Naurex, GlaxoSmithKline, Eli Lilly and Co., Naurex, and others.
Scope of Depression Drugs Market
Product Type Segments
- Tricyclice Antidepressants
- Serotonin-Norepinephrine Inhibitors
- Atypical Antipsychotics
- Selective Serotonin Reuptake Inhibitors
- Benzodiazepines, Tetracyclic Antidepressants
- Monoamine Oxidase Inhibitors
- Others
Application Segments
- Clinics and Hospitals
- Research centres
Geographical Segments
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Spain
- Others
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Others
- RoW
- South America
- Middle East
- Africa
Related Reports:
- Sleeping Aids Market (By Product Type: Mattresses and Pillows, Sleep Laboratories, Medication, Sleep Apnea Devices; By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
- Uveitis Treatment Market (By Type: Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, And Panuveitis; By Treatment Type: Anti-Inflammatory Medications, Antibiotic/Antiviral Medications, And Immunosuppressive Medications; By Geography: North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
- Biopharmaceuticals Market (Monoclonal Antibodies, Recombinant Proteins, Granulocyte Colony-Stimulating Factor, Interferon, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins; Oncology, Inflammatory Infectious Diseases, Metabolic Disorders, Cardiovascular Diseases; North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients’ objectives. We also provide customized data packs proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visit https://www.variantmarketresearch.com
You can connect with us on LinkedIn here @ https://www.linkedin.com/company/variant-market-research
Contact Us:
Michael Mendes
Head – Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco,
CA 94105,United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: michael.mendes@variantmarketresearch.com
Email: help@variantmarketresearch.com
